Cargando…

RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer

OBJECTIVE: RAS gene testing on tumor tissue biopsies is required for metastatic colorectal cancer (CRC) patients. However, it is infeasible for patients after curative surgery and repeated biopsy. This study is aimed at evaluating the consistency of RAS genes in patient's plasma, stool, and tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Liuying, Wang, Yuanhe, Zhou, Yang, Dong, Qian, Liu, Yunpeng, Zhang, Jingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174943/ https://www.ncbi.nlm.nih.gov/pubmed/32351996 http://dx.doi.org/10.1155/2020/5419634

Ejemplares similares

Detection of Hypermethylated Spastic Paraplegia-20 in Stool Samples of Patients with Colorectal Cancer
por: Zhang, Hao, et al.
Publicado: (2013)

Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes
por: Däbritz, J, et al.
Publicado: (2005)

DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer
por: Macedo, F, et al.
Publicado: (2022)

Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
por: Liu, Yi, et al.
Publicado: (2020)

Detection of Cryptosporidium in stool samples of immunocompromised patients
por: Vanathy, K, et al.
Publicado: (2017)

Fast simultaneous detection of K-RAS mutations in colorectal cancer
por: Chang, Ya-Sian, et al.
Publicado: (2009)

MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection
por: Chang, Pi-Yueh, et al.
Publicado: (2016)

Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis
por: Zhou, Mingyi, et al.
Publicado: (2016)

CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
por: PINTO, Thiago David Alves, et al.
Publicado: (2021)

The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.
por: Fox, J. C., et al.
Publicado: (1998)

Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer.
por: Kopreski, M. S., et al.
Publicado: (1997)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Weisong, et al.
Publicado: (2021)

Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer
por: Zhang, Liqun, et al.
Publicado: (2019)

Surgical Management of Colorectal Liver Metastases: Prognostic Indicators and the Impact of RAS Mutation Status
por: Wei, Steven H., et al.
Publicado: (2015)

Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
por: Fernández Montes, A., et al.
Publicado: (2022)

Evaluation of LAMP for detection of Shigella from stool samples in children
por: Raghavan, Ramya, et al.
Publicado: (2020)

A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
por: Bando, Hideaki, et al.
Publicado: (2019)

Improved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancer
por: Roperch, Jean-Pierre, et al.
Publicado: (2015)

Methylation pattern of SFRP1 promoter in stool sample is a potential marker for early detection of colorectal cancer
por: Salehi, R., et al.
Publicado: (2012)

Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia
por: Aitchison, Alan, et al.
Publicado: (2022)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022)

Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA
por: Ebner, Derek W., et al.
Publicado: (2021)

Quantitative study of vimentin gene methylation in stool samples for colorectal cancer screening
por: Pakbaz, Behfar, et al.
Publicado: (2019)

Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing
por: Schmiegel, Wolff, et al.
Publicado: (2017)

Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
por: Bando, Hideaki, et al.
Publicado: (2020)

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
por: Vidal, J, et al.
Publicado: (2017)

Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients
por: Makhmalbaf, Mobin, et al.
Publicado: (2022)

Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2020)

Strategies to tackle RAS-mutated metastatic colorectal cancer
por: Patelli, G., et al.
Publicado: (2021)

The impact of RAS mutation on the treatment strategy of colorectal cancer
por: Pirvu, Edvina Elena, et al.
Publicado: (2023)

Culture-Independent Detection of Poliovirus in Stool Samples by Direct RNA Extraction
por: Harrington, Chelsea, et al.
Publicado: (2021)

Development of a rapid homogeneous immunoassay for detection of rotavirus in stool samples
por: Wang, Ye, et al.
Publicado: (2022)

On the robustness of inference of association with the gut microbiota in stool, rectal swab and mucosal tissue samples
por: Sun, Shan, et al.
Publicado: (2021)

Tumor-Derived Exosome-Educated Hepatic Stellate Cells Regulate Lactate Metabolism of Hypoxic Colorectal Tumor Cells via the IL-6/STAT3 Pathway to Confer Drug Resistance
por: Li, Feifei, et al.
Publicado: (2020)

RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients
por: Li, Qian, et al.
Publicado: (2020)

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
por: Brozos-Vázquez, Elena, et al.
Publicado: (2023)

Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer
por: Sasaki, Yusuke, et al.
Publicado: (2016)

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2020)

Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
por: Lastraioli, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7q8k7n127klpsuqpoeic7fv3cv